Youcare Pharmaceutical Group (688658.SH): YKYY025 injection is approved for FDA clinical trials.

Youcare Pharmaceutical Group (688658.SH) announced that its wholly-owned subsidiary Hangzhou Tianlong Pharmaceutical Co., Ltd. (referred to as "Hangzhou Tianlong") recently received a letter from the U.S. Food and Drug Administration (FDA) approving clinical trials of YKYY025 injection to prevent lower respiratory tract diseases caused by respiratory syncytial virus (RSV).